|
|
Epzicom (Abacavir/3TC, Kivexa)
| Brand Name: |
Epzicom |
| Generic Name: |
Abacavir/Lamivudine, ABC/3TC |
| Adult Single Dose: |
One tablet containing 600 mg ABC and 300 mg 3TC (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
|
|
|
- An Overview of Epzicom (Abacavir/3TC, Kivexa) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- FAQs About Epzicom (Regularly Updated)
From The Body's "Ask the Experts" Forums
- Epzicom (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Patient Information About Epzicom (Abacavir/3TC, Kivexa) (PDF) (March 2009)
From GlaxoSmithKline
- GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
- What's New in the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (November 3, 2008)
From AIDSinfo
- Epzicom/Kivexa (Abacavir + Lamivudine) (August 23, 2008)
To read PDF, click here
From AIDS InfoNet
- Epzicom (Epivir + Ziagen) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- The Once-Daily Abacavir/Lamivudine Co-Formulation Proves Its Mettle by Being Both Safe and Effective (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
|
Advertisement
|
E-Mail
Glossary
Share
